”
As soon as the NAL-NL3 prescription became available on the MedRx platform, we updated our software that very same day. After such a positive experience during the NAL trials, we had been eagerly waiting to go live. Our clinicians have all found the transition to the new software seamless and they’re excited to explore the additional modules that weren’t accessible during the trial phase. With these new capabilities, I’m confident it has the potential to help more people than ever, both within our clinics and around the world. -Dr. Adrienne Blechman

























